Data as of Q4 2025 (Dec 31, 2025)

Iron Triangle Partners LP

โ€ขCIK: 1779763โ€ขFiling: Q4 2025

**Iron Triangle Partners LP** manages $875M across a concentrated portfolio of 27 positions. The fund exhibits significant conviction in select names, with top holdings including CRL at $75.7M and ISRG at $53.5M. Further notable allocations include RGEN ($52.5M), MRX ($49.7M), and VCYT ($41.3M). This structure suggests a focused, high-conviction approach targeting established growth and technology sectors.

Total AUM
$874.7M
QoQ Performance
+24.4%
Positions
27
Top 10 Concentration
53.2%
Latest Filing
Q4 2025

Top Holdings Allocation

CRL
ISRG
RGEN
JAZZ
CRL8.7%
ISRG6.1%
RGEN6.0%
JAZZ5.7%
VCYT4.7%
BSX4.6%
WAT4.6%
B7S4.3%

๐Ÿ“ˆ Biggest Buys

ISRG
INTUITIVE SURGICAL INC
NEW
6.1% of portfolio
BSX
BOSTON SCIENTIFIC CORP
NEW
4.6% of portfolio
WAT
WATERS CORP
NEW
4.6% of portfolio
BRKR
BRUKER CORP
NEW
4.3% of portfolio
VRTX
VERTEX PHARMACEUTICALS INC
NEW
4.0% of portfolio

๐Ÿ“‰ Biggest Sells

CVS
CVS HEALTH CORP
-45.8%
3.9% of portfolio
LLY
ELI LILLY & CO
-29.3%
4.3% of portfolio
BTSG
BRIGHTSPRING HEALTH SVCS INC
-27.5%
3.8% of portfolio

Sector Breakdown

Other86.6%
Healthcare13.4%

๐Ÿšช Exited Positionssold since Q3 2025

DC4
DEXCOM INC
SOLD
$57.2M
ABBV
ABBVIE INC
SOLD
$46.4M
MDT
MEDTRONIC PLC
SOLD
$43.2M
GKOS
GLAUKOS CORP
SOLD
$28.0M
THC
TENET HEALTHCARE CORP
SOLD
$27.9M
+9 more exited positions

Changes from Q3 2025

NEW16 new positions
โ†‘8 increased
โ†“3 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023